MECHANISM OF RECOMBINATION BY HIV REVERSE TRANSCRIPTASE
HIV逆转录酶的重组机制
基本信息
- 批准号:2701621
- 负责人:
- 金额:$ 12.07万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1994
- 资助国家:美国
- 起止时间:1994-05-01 至 1999-12-31
- 项目状态:已结题
- 来源:
- 关键词:DNA directed RNA polymerase RNA directed DNA polymerase active sites enzyme mechanism gel electrophoresis genetic recombination genetic regulatory element human immunodeficiency virus nucleic acid biosynthesis nucleic acid chemical synthesis nucleic acid sequence nucleoproteins pancreatic ribonuclease protein structure ribonuclease H transfection
项目摘要
This proposal will focus on the mechanism of human immunodeficiency virus
(HIV) recombination as catalyzed by reverse transcriptase (RT).
Recombination during first strand DNA synthesis (synthesis directed by the
RNA genome of the retrovirus) is presumed to occur by strand transfer.
This process, whereby DNA synthesized on one template (donor) is
transferred to another template (acceptor) for additional elongation,
occurs twice during the retroviral replication cycle. In addition to these
required transfers which occur at the termini of viral templates, other
transfers within internal regions of the genome can also occur. An in
vitro system designed to examine internal strand transfers will be used to
model recombination occurring within internal regions of the donor.
Experiments will evaluate the kinetic parameters associated with this
process and the influence of RT on specific steps (for example, the
dissociation of the nascent DNA from the donor and its association with
the acceptor) with the goal of formulating a model for recombination.
Strand transfer on specific viral sequences with characteristics that may
promote efficient transfer will be examined using a system that can
measure the strand transfer efficiency of any region of RNA. The potential
effect of base misincorporations on transfer efficiency and the frequency
of misincorporation during transfer events will be evaluated. This is
particularly relevant given the low fidelity of DNA synthesis by HIV-RT
and the fact that misincorporation leads to DNA synthesis pausing which
has been proposed to promote transfer. Nucleocapsid protein (NCp) is a
nucleic acid binding protein found in the core of the retroviral virion.
The properties of this protein suggest that it may influence the DNA
synthetic and strand transfer catalysis properties of RT. These
possibilities will be evaluated in the above systems. In addition to the
studies on recombination, the RNase H cleavage specificity of HIV-RT will
be examined, The experiments will use substrates that mimic structures
present during replication to determine how the RT recognizes and cleaves
such structures and to evaluate the spacial and topological arrangement of
the polymerase and RNase H active sites of the RT. Overall, the studies
will offer insight into one of the mechanisms by which retroviruses evolve
and escape both drug therapy and the host immune response. An
understanding of these processes is important for designing drug therapies
or other strategies that target unique RT activities.
该提案将重点关注人类免疫缺陷病毒的机制
(HIV) 重组由逆转录酶 (RT) 催化。
第一链 DNA 合成过程中的重组(由 DNA 引导的合成)
逆转录病毒的RNA基因组)被推测是通过链转移发生的。
在一个模板(供体)上合成 DNA 的这一过程是
转移到另一个模板(受体)以获得额外的伸长,
在逆转录病毒复制周期中发生两次。除了这些
所需的转移发生在病毒模板的末端,其他
基因组内部区域内的转移也可能发生。一个在
旨在检查内部链转移的体外系统将用于
模型重组发生在供体的内部区域。
实验将评估与此相关的动力学参数
过程以及 RT 对特定步骤的影响(例如,
新生DNA与供体的分离及其与
受体),目标是建立重组模型。
特定病毒序列上的链转移具有可能的特征
将使用一个能够促进有效转移的系统进行检查
测量 RNA 任何区域的链转移效率。潜力
碱基错误掺入对转移效率和频率的影响
将评估转移事件期间的错误合并。这是
鉴于 HIV-RT 的 DNA 合成保真度较低,这一点尤其重要
事实上,错误掺入会导致 DNA 合成暂停
已提出促进转移。核衣壳蛋白 (NCp) 是一种
逆转录病毒病毒颗粒核心中发现的核酸结合蛋白。
这种蛋白质的特性表明它可能会影响 DNA
RT 的合成和链转移催化特性。这些
将在上述系统中评估可能性。除了
重组研究中,HIV-RT 的 RNase H 切割特异性将
进行检查,实验将使用模仿结构的基材
复制过程中存在以确定 RT 如何识别和切割
此类结构并评估其空间和拓扑排列
RT 的聚合酶和 RNase H 活性位点。总体而言,研究
将深入了解逆转录病毒进化的机制之一
并逃避药物治疗和宿主免疫反应。一个
了解这些过程对于设计药物疗法很重要
或其他针对独特 RT 活动的策略。
项目成果
期刊论文数量(32)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Duplex structural differences and not 2'-hydroxyls explain the more stable binding of HIV-reverse transcriptase to RNA-DNA versus DNA-DNA.
双链体结构差异而非 2'-羟基解释了 HIV 逆转录酶与 RNA-DNA 的结合比 DNA-DNA 更稳定。
- DOI:10.1093/nar/gkq169
- 发表时间:2010-07
- 期刊:
- 影响因子:14.9
- 作者:Olimpo, Jeffrey T.;DeStefano, Jeffrey J.
- 通讯作者:DeStefano, Jeffrey J.
Alternative divalent cations (Zn²⁺, Co²⁺, and Mn²⁺) are not mutagenic at conditions optimal for HIV-1 reverse transcriptase activity.
- DOI:10.1186/s12858-015-0041-x
- 发表时间:2015-05-03
- 期刊:
- 影响因子:0
- 作者:Achuthan V;DeStefano JJ
- 通讯作者:DeStefano JJ
Human immunodeficiency virus reverse transcriptase base misincorporations can promote strand transfer.
人类免疫缺陷病毒逆转录酶碱基错误掺入可以促进链转移。
- DOI:10.1007/s007050070113
- 发表时间:2000
- 期刊:
- 影响因子:2.7
- 作者:Diaz,L;Cristofaro,JV;DeStefano,JJ
- 通讯作者:DeStefano,JJ
Detection of cyclic diguanylate G-octaplex assembly and interaction with proteins.
检测环状二鸟苷酸 G-octaplex 组装以及与蛋白质的相互作用。
- DOI:10.1371/journal.pone.0053689
- 发表时间:2013
- 期刊:
- 影响因子:3.7
- 作者:Lieberman,OriJ;DeStefano,JeffreyJ;Lee,VincentT
- 通讯作者:Lee,VincentT
Selection of primer-template sequences that bind human immunodeficiency virus reverse transcriptase with high affinity.
- DOI:10.1093/nar/gkj426
- 发表时间:2006
- 期刊:
- 影响因子:14.9
- 作者:DeStefano JJ;Cristofaro JV
- 通讯作者:Cristofaro JV
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JEFFREY J DESTEFANO其他文献
JEFFREY J DESTEFANO的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JEFFREY J DESTEFANO', 18)}}的其他基金
Using new Next Generation Sequencing (NGS) approaches to analyze the fidelity of HIV reverse transcription in Endogenous Reverse Transcription reactions (ERT)
使用新的下一代测序 (NGS) 方法来分析内源性逆转录反应 (ERT) 中 HIV 逆转录的保真度
- 批准号:
10759845 - 财政年份:2023
- 资助金额:
$ 12.07万 - 项目类别:
Development and Evaluation of Novel Aptamer-based Therapeutics Targeting SARS-CoV-2 in a Physiologically-Relevant Model of Human Airway Epithelium
在人类气道上皮生理相关模型中针对 SARS-CoV-2 的新型适体疗法的开发和评估
- 批准号:
10449392 - 财政年份:2021
- 资助金额:
$ 12.07万 - 项目类别:
Development and Evaluation of Novel Aptamer-based Therapeutics Targeting SARS-CoV-2 in a Physiologically-Relevant Model of Human Airway Epithelium
在人类气道上皮生理相关模型中针对 SARS-CoV-2 的新型适体疗法的开发和评估
- 批准号:
10287842 - 财政年份:2021
- 资助金额:
$ 12.07万 - 项目类别:
Biochemistry of HIV reverse transcriptase fidelity and inhibitor interactions
HIV逆转录酶保真度和抑制剂相互作用的生物化学
- 批准号:
9538330 - 财政年份:2016
- 资助金额:
$ 12.07万 - 项目类别:
Biochemistry of HIV reverse transcriptase fidelity and inhibitor interactions
HIV逆转录酶保真度和抑制剂相互作用的生物化学
- 批准号:
9064995 - 财政年份:2016
- 资助金额:
$ 12.07万 - 项目类别:
Development of an HIV reverse transcriptase aptamer-based detection assay
基于 HIV 逆转录酶适体的检测方法的开发
- 批准号:
8846946 - 财政年份:2014
- 资助金额:
$ 12.07万 - 项目类别:
MECHANISM OF RECOMBINATION BY HIV REVERSE TRANSCRIPTASE
HIV逆转录酶的重组机制
- 批准号:
2189459 - 财政年份:1994
- 资助金额:
$ 12.07万 - 项目类别:
MECHANISM OF RECOMBINATION BY HIV REVERSE TRANSCRIPTASE
HIV逆转录酶的重组机制
- 批准号:
6627193 - 财政年份:1994
- 资助金额:
$ 12.07万 - 项目类别:
Mechanism of recombination by HIV reverse transcriptase
HIV逆转录酶重组机制
- 批准号:
7028364 - 财政年份:1994
- 资助金额:
$ 12.07万 - 项目类别:
MECHANISM OF RECOMBINATION BY HIV REVERSE TRANSCRIPTASE
HIV逆转录酶的重组机制
- 批准号:
6490080 - 财政年份:1994
- 资助金额:
$ 12.07万 - 项目类别:
相似海外基金
Emerging mechanisms of viral gene regulation from battles between host and SARS-CoV-2
宿主与 SARS-CoV-2 之间的战斗中病毒基因调控的新机制
- 批准号:
10725416 - 财政年份:2023
- 资助金额:
$ 12.07万 - 项目类别:
Characterization of JT-4-173, a Potent Antiviral that Inhibits HIV-1 by a Novel Mechanism of Action
JT-4-173 的表征,一种通过新颖作用机制抑制 HIV-1 的强效抗病毒药物
- 批准号:
10762518 - 财政年份:2023
- 资助金额:
$ 12.07万 - 项目类别:
PAIRS: Validating telomerase reverse transcriptase (TERT) as an intrinsic vulnerability toward sensitizing cancer to radiation
配对:验证端粒酶逆转录酶 (TERT) 作为癌症对辐射敏感的内在脆弱性
- 批准号:
10718390 - 财政年份:2023
- 资助金额:
$ 12.07万 - 项目类别:
SBIR Topic #446 Phase I -Development of Senotherapeutic Agents for Cancer Treatment
SBIR主题
- 批准号:
10929719 - 财政年份:2023
- 资助金额:
$ 12.07万 - 项目类别:
Recognition of Synthetic Unnatural Base Pairs by RNA Polymerase
RNA 聚合酶对合成非天然碱基对的识别
- 批准号:
10561543 - 财政年份:2023
- 资助金额:
$ 12.07万 - 项目类别: